{"id":"W2949614109","doi":"10.1002/hon.106_2630","title":"PHASE 1B KEYNOTE‐013 STUDY OF PEMBROLIZUMAB IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE: RESULTS OF >4 YEARS OF FOLLOW‐UP","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Pembrolizumab; Autologous stem-cell transplantation; Oncology; Cohort; Population; Lymphoma; Progression-free survival; Surgery; Chemotherapy; Hodgkin lymphoma; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001866785,0.0002483044,0.001611851,0.0002104287,0.00001097066,0.000002905576,0.0001482831,0.0002831141,0.0001271276],"category_scores_gemma":[0.0001632312,0.000169396,0.0001541252,0.0003557929,0.0001827641,0.00004900662,0.0001113603,0.0001063125,0.0000293947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002344424,"about_ca_system_score_gemma":0.0002221968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001137584,"about_ca_topic_score_gemma":0.000155511,"domain_scores_codex":[0.9974524,0.0002263437,0.00103239,0.0004864142,0.0004588984,0.0003435246],"domain_scores_gemma":[0.9981755,0.0004500248,0.0005648598,0.0005073244,0.0001837384,0.000118578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04097582,0.1041858,0.837823,0.0001696306,0.0003108359,0.0005227425,0.001049646,0.00000331078,0.0001363018,0.0001540765,0.0003349304,0.01433389],"study_design_scores_gemma":[0.2250726,0.04096133,0.7314388,0.0001799886,0.000202998,0.00003435875,0.0003539596,0.00001746084,0.001077283,0.00002310543,0.0005075365,0.0001305866],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973922,0.0001092778,0.000001484442,0.0001667938,0.0001167227,0.001563351,0.00004417628,0.00001745576,0.0005885614],"genre_scores_gemma":[0.9993392,0.00001177296,0.0003241577,0.00007444459,0.000009807335,0.0001315039,0.00004181752,0.00001868353,0.00004857319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1840968,"threshold_uncertainty_score":0.6907768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01381244760435406,"score_gpt":0.2820307867718148,"score_spread":0.2682183391674607,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}